Novo Integrated Sciences Inc Stock

$0.50+0.04 (+8.7%)
Updated May 24, 2024
NVOS Price
Fair Value Price
Market Cap
52 Week Low
52 Week High
Dividend Yield
Gross Margin
Operating Margin
Profit Margin
Debt to Equity
Operating Cash Flow
Next Earnings
Jul 15, 2024
Next Dividend

NVOS Overview

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services, and Product Manufacturing and Development. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community based home care physiotherapy, community based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement home and community, and long-term care sectors. Further, it offers medical technology services, such as telemedicine and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company operates 16 owned clinics. The company was incorporated in 2000 and is based in Bellevue, Washington. Novo Integrated Sciences, Inc. operates as a subsidiary of ALMC-ASAP Holdings, Inc.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NVOS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NVOS is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NVOS is good value based on its book value relative to its share price (0.43x), compared to the US Medical Care Facilities industry average (4.59x)
P/B vs Industry Valuation
NVOS is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more NVOS due diligence checks available for Premium users.

Be the first to know about important NVOS news, forecast changes, insider trades & much more!



NVOS fair value

Fair Value of NVOS stock based on Discounted Cash Flow (DCF)
Fair Value
Undervalued by
NVOS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NVOS price to earnings (PE)

For valuing profitable companies with steady earnings

NVOS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
NVOS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NVOS's financial health

Profit margin

Net Income
Profit Margin
NVOS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NVOS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Debt to equity
NVOS's short-term liabilities ($9.96M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NVOS's short-term assets ($5.02M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NVOS's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NVOS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

NVOS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NVOS vs Medical Care Facility Stocks

TickerMarket Cap1d %P/EP/B

Novo Integrated Sciences Stock FAQ

What is Novo Integrated Sciences's quote symbol?

(NASDAQ: NVOS) Novo Integrated Sciences trades on the NASDAQ under the ticker symbol NVOS. Novo Integrated Sciences stock quotes can also be displayed as NASDAQ: NVOS.

If you're new to stock investing, here's how to buy Novo Integrated Sciences stock.

What is the 52 week high and low for Novo Integrated Sciences (NASDAQ: NVOS)?

(NASDAQ: NVOS) Novo Integrated Sciences's 52-week high was $5.38, and its 52-week low was $0.42. It is currently -90.68% from its 52-week high and 20.67% from its 52-week low.

How much is Novo Integrated Sciences stock worth today?

(NASDAQ: NVOS) Novo Integrated Sciences currently has 19,054,523 outstanding shares. With Novo Integrated Sciences stock trading at $0.50 per share, the total value of Novo Integrated Sciences stock (market capitalization) is $9.57M.

Novo Integrated Sciences stock was originally listed at a price of $4,000.00 in Aug 5, 2005. If you had invested in Novo Integrated Sciences stock at $4,000.00, your return over the last 18 years would have been -99.99%, for an annualized return of -39.29% (not including any dividends or dividend reinvestments).

How much is Novo Integrated Sciences's stock price per share?

(NASDAQ: NVOS) Novo Integrated Sciences stock price per share is $0.50 today (as of May 24, 2024).

What is Novo Integrated Sciences's Market Cap?

(NASDAQ: NVOS) Novo Integrated Sciences's market cap is $9.57M, as of May 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Novo Integrated Sciences's market cap is calculated by multiplying NVOS's current stock price of $0.50 by NVOS's total outstanding shares of 19,054,523.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.